Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 79

Results For "EU"

5165 News Found

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada
People | March 09, 2022

Dr. Andreas Amrein joins Advanced Clinical to lead expansion in APAC, Europe and Canada

With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies


Ankura launches pharmaceutical data integrity solution
News | March 08, 2022

Ankura launches pharmaceutical data integrity solution

Data integrity early warning system assists pharmaceutical clients in proactively identifying and managing data integrity challenges in line with regulatory guidelines


Cionic’s Neural Sleeve granted USFDA clearance
Medical Device | March 08, 2022

Cionic’s Neural Sleeve granted USFDA clearance

Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities


ENTOD Pharmaceuticals launches glaucoma awareness campaign
Public Health | March 08, 2022

ENTOD Pharmaceuticals launches glaucoma awareness campaign

Raising awareness about glaucoma is crucial in India where it is the leading cause of irreversible blindness with at least 12 million people affected and almost 1.2 million people blind from the disease


Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment
Drug Approval | March 08, 2022

Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide ointment

Nystatin and Triamcinolone Acetonide ointment is indicated for the treatment of cutaneous candidiasis


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe


Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases
Biotech | March 07, 2022

Elixirgen Therapeutics and Taisho Pharmaceutical tie-up to cure ageing-associated diseases

Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.


IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year
News | March 07, 2022

IOL Chemicals and Pharmaceuticals to limit capex at Rs 150 crore per year

The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business


HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
Biotech | March 07, 2022

HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO

According to statistics, the global inhalation drug market reached US $ 25 billion in 2020


Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.
Biotech | March 06, 2022

Aquestive Therapeutics and Haisco Pharmaceutical partner for riluzole in China.

Around 85% of ALS patients suffer from a progressive loss of bulbar functionality